5[1]Millar TW,Hunter AM,Horne NW.Intrapleural immunotheropy with CP in recurrent malignant pleural effusions.Thorax,1980,35:856～860.
6Casciato DA,Lowitz BB.Manual of clinical oncology[M].Philadelphia,4th ed.2000,558-561.
7Correale P,Campoccia G,Tsang KY,et al.Recruitment of dendritic cells and enhanced antigen-specific immune reactivity in cancer patients treated with hr-GM-CSF (Molgramostim) and hr-IL-2.results from a phase Ib clinical trial[J].Eur J Cancer,2001,37(7):892-902.
8Pan PY,Li Y,Li Q,et al.In situ recruitment of antigen-presenting cells by intratumoral GM-CSF gene delivery[J].Cancer Immunol Immunother,2004,53(1):17-25.
9Wong RJ,Patel SG,Kim S,et al.Cytokine gene transfer enhances herpes oncolytic therapy in murine squamous cell carcinoma[J].Hum Gene Ther,2001,12(3):253-265.
10Mastrangelo MJ,Maguire HC Jr,Eisenlohr LC,et al.Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma[J].Cancer Gene Ther,1999,6(5):409-422.
2Li QJ,VainganKar S,Sladek FM.Novel nuclear farget for throm-bin activation of the EIKL transcription factor leaders to chemokine gene expression[J].Blood,2000,96(12):3696-3706.
